Improved modulators of coagulation factors

Details for Australian Patent Application No. 2005238490 (hide)

Owner Regado Biosciences, Inc.

Inventors Rusconi, Christopher

Agent Davies Collison Cave

Pub. Number AU-B-2005238490

PCT Pub. Number WO2005/106042

Priority 60/564,873 22.04.04 US

Filing date 22 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 18 November 2010

International Classifications

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/106042 Priority application(s): WO2005/106042

18 November 2010 Application Accepted

  Published as AU-B-2005238490

17 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238493-Labeling of rapamycin using rapamycinspecific methylases

2005238489-Kits and reagents for use in diagnosis and prognosis of genomic disorders